The KCNK16 mutation causing TALK-1 gain of function results in the inhibition of glucose-stimulated membrane potential depolarization and reduced endoplasmic reticulum Ca2+ storage, leading to a form of maturity-onset diabetes of the young (11). Here, KCNK16 is linked to type 2 diabetes mellitus.